John Rothrock, MD is the Vice-Chair of the Department of Neurology and professor of neurology at The George Washington University School of Medicine & Health Sciences. Dr. Rothrock received his medical degree from the University of Virginia and completed his internship and residency training in Neurology at the University of Arizona.
In 1983 he joined the Neurosciences faculty at the University of California, San Diego (UCSD), where he established and directed the UCSD Stroke Center and, subsequently, the UCSD Headache Center. He and his colleagues assisted in the development of such therapies as intravenous t-PA for acute stroke therapy, warfarin for stroke prevention in individuals with atrial fibrillation, self-injectable sumatriptan for acute migraine, and divalproex sodium and topiramate for migraine prophylaxis. While at UCSD Rothrock sequentially was promoted from assistant professor to full professor.
In 1994 he left UCSD to serve as chair of Neurology and, subsequently, as associate dean for clinical research at the University of South Alabama before accepting a position as professor, vice chair and medical director of Neurology at the University of Alabama/Birmingham (UAB) in 2006. While at UAB Rothrock continued his clinical research in the areas of stroke and migraine, exploring new therapies for primary intracerebral hemorrhage and acute ischemic stroke and assisting in the development of onabotulinumtoxinA for chronic migraine.
From 2012 to 2015, Dr. Rothrock joined The University of Nevada (Reno) School of Medicine and was appointed chair of the department of Neurology and director of the Institute for the Neurosciences at Renown Regional Medical Center, the medical school’s primary teaching hospital.
Dr. Rothrock has been cited in America's Top Doctors and Best Doctors in America in each of the past 13 years. In 2007 he was cited in Men's Health magazine as one of the 20 top neurologists in America, and in 2008 he received the same citation in Women's Health.